Dyne Therapeutics (DYN) Cash from Operations (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Cash from Operations data on file, last reported at 144922000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 36.86% year-over-year to 144922000.0 in Q1 2026; TTM through Mar 2026 was 442236000.0, a 38.32% decrease from a year earlier, with the FY2025 full-year figure at 403207000.0, down 37.91% from the prior year.
• Cash from Operations for Q1 2026 stood at 144922000.0, down from 111832000.0 in the prior quarter.
• Over the last five years, Cash from Operations for DYN reached as high as 29192000.0 in Q4 2022 and fell as low as 144922000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 69547117.65 across 5 years, with a median of 55642000.0 in 2023.
• On a YoY basis, Cash from Operations climbed as much as 33.02% in 2022 and fell as far as 175.86% in 2022.
• Year by year, Cash from Operations stood at 29192000.0 in 2022, then decreased by 19.92% to 35006000.0 in 2023, then tumbled by 140.92% to 84335000.0 in 2024, then plunged by 32.6% to 111832000.0 in 2025, then declined by 29.59% to 144922000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 144922000.0 in Q1 2026, 111832000.0 in Q4 2025, and 90779000.0 in Q3 2025.